Latest & greatest articles for rheumatoid arthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on rheumatoid arthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on rheumatoid arthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for rheumatoid arthritis

61. The effects and safety of modified Si-miao pill in combination with DMARDs in the treatment of rheumatoid arthritis

The effects and safety of modified Si-miao pill in combination with DMARDs in the treatment of rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

62. Evaluation of quality of life and pain in patients with rheumatoid arthritis with anti-TNF therapy in terms of their feet: systematic review

Evaluation of quality of life and pain in patients with rheumatoid arthritis with anti-TNF therapy in terms of their feet: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

63. Equivalence or non-inferiority of infliximab, etanercept and adalimumab biosimilars in patients with rheumatoid arthritis: systematic review and meta-analysis

Equivalence or non-inferiority of infliximab, etanercept and adalimumab biosimilars in patients with rheumatoid arthritis: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

64. Equity of outcome measures in rheumatoid arthritis

Equity of outcome measures in rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

65. Electroacupuncture for rheumatoid arthritis: a systematic review and meta-analysis

Electroacupuncture for rheumatoid arthritis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

66. Traditional Chinese Medicine on treating active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

Traditional Chinese Medicine on treating active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

67. Janus kinase inhibitors for rheumatoid arthritis: effectiveness and value

Janus kinase inhibitors for rheumatoid arthritis: effectiveness and value Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

68. A systematic review of pain measurement in skin conditions and rheumatoid arthritis to inform on validation of pain instrument for hidradenitis suppurativa

A systematic review of pain measurement in skin conditions and rheumatoid arthritis to inform on validation of pain instrument for hidradenitis suppurativa Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

69. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis

Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

70. Disease-modifying anti-rheumatic drug-free remission in rheumatoid arthritis: a sustainable outcome? A systematic review

Disease-modifying anti-rheumatic drug-free remission in rheumatoid arthritis: a sustainable outcome? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

71. Total knee arthroplasty (TKA) for treatment of rheumatoid arthritis (RA): a systematic review of randomized controlled trial

Total knee arthroplasty (TKA) for treatment of rheumatoid arthritis (RA): a systematic review of randomized controlled trial Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

72. Correlates and determinants of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review

Correlates and determinants of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

73. Association of telomere length with risk of rheumatoid arthritis: a meta-analysis and Mendelian randomization

Association of telomere length with risk of rheumatoid arthritis: a meta-analysis and Mendelian randomization Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

74. A systematic review on effect of Ayurveda interventions in the management of rheumatoid arthritis

A systematic review on effect of Ayurveda interventions in the management of rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

75. Systematic review of serum biomarkers in rheumatoid arthritis-interstitial lung disease

Systematic review of serum biomarkers in rheumatoid arthritis-interstitial lung disease Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

76. The generalizability of glucocorticoid trials in rheumatoid arthritis: protocol for a systematic review and meta-analysis

The generalizability of glucocorticoid trials in rheumatoid arthritis: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

77. A systematic review of bacterial infection exposures as a risk for rheumatoid arthritis

A systematic review of bacterial infection exposures as a risk for rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

78. The quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II

The quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO

79. Comparative efficacy and safety of biosimilar-rituximab and originator-rituximab in rheumatoid arthritis and non-Hodgkin's lymphoma: a meta-analysis

Comparative efficacy and safety of biosimilar-rituximab and originator-rituximab in rheumatoid arthritis and non-Hodgkin's lymphoma: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

80. Defining refractory disease in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis

Defining refractory disease in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO